Carregant...
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
Currently, the expansion of the novel human respiratory coronavirus (known as SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], COVID-2019 [coronavirus disease 2019], or 2019-nCoV [2019 novel coronavirus]) has stressed the need for therapeutic alternatives to alleviate and stop this new...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7179632/ https://ncbi.nlm.nih.gov/pubmed/32152082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00399-20 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|